Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Base de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Neurocirugia (Astur) ; 14(4): 309-21; discussion 321-2, 2003 Sep.
Artículo en Español | MEDLINE | ID: mdl-14506554

RESUMEN

A relationship between Central Nervous System and coagulation has been known since the work by Goodnight et al5. When an encephalic injury occurs tissue damage causes the release of thromboplastin-related products, mainly the Tissular Factor. This release produces an activation of the coagulation system specially through its extrinsic path. With this physiopathologic basis we attempt to improve the knowledge of this relation by performing a prospective study at the Intensive Care Unit of our Hospital. The study included 67 patients with cranioencephalic trauma alone, with an average Glasgow coma scale score of 10 and a control group consisting of 40 healthy subjects. Two peripheral vein blood extractions were performed, at admission and 24 hours later. Global coagulation parameters (prothrombin time, activated partial thromboplastin time, platelet count and fibrinogen), hypercoagulability markers (prothrombin fragments F1+2 and thrombin-antithrombin complex (TAT)) and thrombolisis markers (D-dimer) were determined. Our results show that early after head trauma an increase in fragments F1+2, TAT and Ddimer occur. After the first 24 hours a significant decrease in hypercoagulability markers levels is detected. Modification of the global coagulation parameters was also detected. In conclusion, early after a cranioencephalic trauma a simultaneous state of hypercoagulability and thrombolysis occur which may have the purpose of improving the hemostatic balance.


Asunto(s)
Lesiones Encefálicas/sangre , Antitrombinas/metabolismo , Trastornos de la Coagulación Sanguínea/diagnóstico , Trastornos de la Coagulación Sanguínea/metabolismo , Plaquetas/metabolismo , Lesiones Encefálicas/metabolismo , Femenino , Productos de Degradación de Fibrina-Fibrinógeno/metabolismo , Fibrinógeno/metabolismo , Hemostasis/fisiología , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Tiempo de Protrombina , Trombina/metabolismo
2.
Infusionsther Klin Ernahr ; 14(5): 196-201, 1987 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-3119480

RESUMEN

Due to the metabolic alterations following surgery, glucose is not completely oxidized but is converted into glycogen and lipids. Therefore we analysed 2 groups of 15 patients following surgery. They received parenteral nutrition with identical nitrogen (N = 0.28 g/kg/d) and lipid (1.5 g/kg/d) intake, whereby only the composition of carbohydrates was varied. Group I received exclusively glucose = 0.22 g/kg/h, and group II the combination fructose-glucose-xylitol in a proportion of 2:1:1 at the same infusion rate. The study lasted approximately 10 days. We found decreased exogenous insulin requirements and an increase in the NEFA levels with a maximum on the 3rd and 4th day in group II. There were no significant differences in the levels of either albumin, prealbumin or retinol-binding protein, nor were any hepatic or renal alterations related to the xylitol infusion observed. Xylituria was 6.13 +/- 3% of the amount infused. In our opinion, the partial substitution of glucose in group II led to a better utilisation of the infused energy supply, and to less insulin stimulation, which facilitated the mobilization of endogenous energy sources such as fatty acids, although we did not succeed in increasing the protein synthesis.


Asunto(s)
Ingestión de Energía , Metabolismo Energético , Nutrición Parenteral Total , Complicaciones Posoperatorias/metabolismo , Estrés Fisiológico/metabolismo , Aminoácidos de Cadena Ramificada/sangre , Glucemia/metabolismo , Nitrógeno de la Urea Sanguínea , Ácidos Grasos no Esterificados/sangre , Fructosa/administración & dosificación , Enfermedades Gastrointestinales/cirugía , Solución Hipertónica de Glucosa , Humanos , Proteínas de Unión al Retinol/metabolismo , Albúmina Sérica/metabolismo , Xilitol/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA